Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: A prospective randomized clinical trial

Transfusion

Volumn 47, Issue 3, 2007, Pages 379-384

  Moonen, Adrianus F C M ^a   Knoors, Nico T ^a   Van Os, Johannes J ^a   Verburg, Aart D ^a   Pilot, Peter ^a,b  

^a Sittard Geleen Heerlen   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANESTHESIA; ARTICLE; BLOOD FILTRATION; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; FEVER; HEMOFILTRATION; HEMOGLOBINS; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED;

EID: 33847025968     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01127.x     Document Type: Article

References (24)

1. Vamvakas EC, Moore SB. Total potential frequency of autologous blood transfusion in Olmsted County, MN. Mayo Clin Proc 1995;70:37-44.
2. Pola E, Papaleo P, Santoliquido A, et al. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg Am 2004;86:57-61.
3. Goldberg MA, McCutchen JW, Jove M, et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996;25:544-52.
4. de Andrade JR, Jove M, Landon G, et al. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996;25:533-42.
5. Faris PM, Ritter MA. Epoetin alfa: a bloodless approach for the treatment of perioperative anemia. Clin Orthop 1998;357:60-7.
6. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002;84:1299-304.
7. Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998;158:610-6.
8. Mercuriali F, Inghilleri G, Biffi E. New approach to preoperative autologous blood donation (PABD). Int J Artif Organs 2000;23-4:221-31.
9. Colwell CW Jr, Beutler E, West C, Hardwick ME, Morris BA. Erythrocyte viability in blood salvaged during total joint arthroplasty with cement. J Bone Joint Surg Am 2002;84:23-5.
10. Huet C, Salmi LR, Fergusson D, et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999;89:861-9.
11. Strumper D, Weber EW, Gielen-Wijffels S, et al. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion 2004;44:1567-71.
12. Southern EP, Huo MH, Mehta JR, Keggi KJ. Unwashed wound drainage blood: what are we giving our patients? Clin Orthop 1995;320:235-46.
13. Slappendel R, Dirksen R, Weber EW, van der Schaaf DB. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand 2003;74:569-75.
14. Andersson I, Tylman M, Bengtson JP, Bengtsson A. Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee arthroplasty. Can J Anaesth 2001;48:251-5.
15. Handel M, Winkler J, Hornlein RF, et al. Increased interleukin-6 in collected drainage blood after total knee arthroplasty: an association with febrile reactions during retransfusion. Acta Orthop Scand 2001;72:270-2.
16. Wheeler TJ, Tobias JD. Complications of autotransfusion with salvaged blood. J Post Anesth Nurs 1994;9:150-2.
17. Jacobs LM, Hsieh JW. A clinical review of autotransfusion and its role in trauma. JAMA 1984;251:3283-7.
18. Murray DJ, Gress K, Weinstein SL. Coagulopathy after reinfusion of autologous scavenged red blood cells. Anesth Analg 1992;75:125-9.
19. Moonen AF, Pilot P, Vossen RC, Bas BM, van Os JJ. The amount of hemolysis in retransfusion after total hip and knee arthroplasty with the Bellovac ABT system [De mate van hemolyse bij retransfusie met behulp van het Bellovac ABT systeem bij artroplastieken van heup-en kniegewicht]. Ned Tijdschr Orthopaedie 2003;10:150-4.
20. Healy W, Pfeifer BA, Kurtz SR, et al. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop 1994;299:53-9.
21. Dalen T, Nilsson KG, Engstrom KG. Fever and autologous blood retransfusion after total knee arthroplasty: a prospective study of 40 autotransfusion events in 21 patients. Acta Orthop Scand 2002;73:321-5.
22. Pilot P, Verburg A, Moonen A, et al. Limited blood use; success due to restrictive policy, education and awareness [Bloedverbruik aan banden; Succes dankzij restrictief transfusiebeleid, schooling en bewustwording]. Med Contact 2005;60-37:1467-9.
23. Pilot P, Verburg A, Moonen A, et al. Feasibility of early cardiopulmonary exercise testing after total hip arthroplasty. TATM 2005;7(Suppl):68(A33).
24. Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 2002;84-A:216-20.